Vineti creates software solutions to drive and scale personalized therapies. Its Personalized Therapy Management (PTM) platform delivers simplicity, compliance and patient safety to medicine’s most complex supply chain, providing the next-generation technology advanced therapies need. The Vineti platform also provides actionable insights to continually optimize the cell and gene therapy process, accelerating time to revenue and decreasing costs. Vineti partners with small and large pharmaceutical developers and offers the only independent platform to have been part of a successful, expedited cell therapy approval. The company supports more than 170 leading medical centres worldwide. Vineti is based in San Francisco, California.